Report Summary
In 2020, the global Ocular Drug Delivery Technology market size was million US$ and it is expected to reach million US$ by the end of 2027, with a CAGR of during 2021-2027.
This report focuses on the global Ocular Drug Delivery Technology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ocular Drug Delivery Technology development in United States, Europe and China.
The key players covered in this study
OCULAR THERAPEUTIX
Alimera Sciences
Allergan
Valeant Pharmaceuticals International
EyeGate Pharma
Envisia Therapeutics
Clearside Biomedical
Graybug Vision
Santen Pharmaceutical
Taiwan Liposome Company
Market segment by Type, the product can be split into
Glaucoma
Macular Degeneration
Diabetic Retinopathy
Cataract
Diabetic Macular Edema
Dry Eye Syndrome
Others
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Ocular Drug Delivery Technology status, future forecast, growth opportunity, key market and key players.
To present the Ocular Drug Delivery Technology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Ocular Drug Delivery Technology are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ocular Drug Delivery Technology Market Size Growth Rate by Type (2017-2027)
1.4.2 Glaucoma
1.4.3 Macular Degeneration
1.4.4 Diabetic Retinopathy
1.4.5 Cataract
1.4.6 Diabetic Macular Edema
1.4.7 Dry Eye Syndrome
1.4.8 Others
1.5 Market by Application
1.5.1 Global Ocular Drug Delivery Technology Market Share by Application (2017-2027)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Ophthalmic Clinics
1.5.5 Homecare Settings
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Ocular Drug Delivery Technology Market Size
2.2 Ocular Drug Delivery Technology Growth Trends by Regions
2.2.1 Ocular Drug Delivery Technology Market Size by Regions (2017-2027)
2.2.2 Ocular Drug Delivery Technology Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Ocular Drug Delivery Technology Market Size by Manufacturers
3.1.1 Global Ocular Drug Delivery Technology Revenue by Manufacturers (2017-2020)
3.1.2 Global Ocular Drug Delivery Technology Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Ocular Drug Delivery Technology Market Concentration Ratio (CR5 and HHI)
3.2 Ocular Drug Delivery Technology Key Players Head office and Area Served
3.3 Key Players Ocular Drug Delivery Technology Product/Solution/Service
3.4 Date of Enter into Ocular Drug Delivery Technology Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Ocular Drug Delivery Technology Market Size by Type (2017-2020)
4.2 Global Ocular Drug Delivery Technology Market Size by Application (2017-2020)
5 United States
5.1 United States Ocular Drug Delivery Technology Market Size (2017-2020)
5.2 Ocular Drug Delivery Technology Key Players in United States
5.3 United States Ocular Drug Delivery Technology Market Size by Type
5.4 United States Ocular Drug Delivery Technology Market Size by Application
6 Europe
6.1 Europe Ocular Drug Delivery Technology Market Size (2017-2020)
6.2 Ocular Drug Delivery Technology Key Players in Europe
6.3 Europe Ocular Drug Delivery Technology Market Size by Type
6.4 Europe Ocular Drug Delivery Technology Market Size by Application
7 China
7.1 China Ocular Drug Delivery Technology Market Size (2017-2020)
7.2 Ocular Drug Delivery Technology Key Players in China
7.3 China Ocular Drug Delivery Technology Market Size by Type
7.4 China Ocular Drug Delivery Technology Market Size by Application
8 Japan
8.1 Japan Ocular Drug Delivery Technology Market Size (2017-2020)
8.2 Ocular Drug Delivery Technology Key Players in Japan
8.3 Japan Ocular Drug Delivery Technology Market Size by Type
8.4 Japan Ocular Drug Delivery Technology Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Ocular Drug Delivery Technology Market Size (2017-2020)
9.2 Ocular Drug Delivery Technology Key Players in Southeast Asia
9.3 Southeast Asia Ocular Drug Delivery Technology Market Size by Type
9.4 Southeast Asia Ocular Drug Delivery Technology Market Size by Application
10 India
10.1 India Ocular Drug Delivery Technology Market Size (2017-2020)
10.2 Ocular Drug Delivery Technology Key Players in India
10.3 India Ocular Drug Delivery Technology Market Size by Type
10.4 India Ocular Drug Delivery Technology Market Size by Application
11 Central & South America
11.1 Central & South America Ocular Drug Delivery Technology Market Size (2017-2020)
11.2 Ocular Drug Delivery Technology Key Players in Central & South America
11.3 Central & South America Ocular Drug Delivery Technology Market Size by Type
11.4 Central & South America Ocular Drug Delivery Technology Market Size by Application
12 International Players Profiles
12.1 OCULAR THERAPEUTIX
12.1.1 OCULAR THERAPEUTIX Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ocular Drug Delivery Technology Introduction
12.1.4 OCULAR THERAPEUTIX Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.1.5 OCULAR THERAPEUTIX Recent Development
12.2 Alimera Sciences
12.2.1 Alimera Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ocular Drug Delivery Technology Introduction
12.2.4 Alimera Sciences Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.2.5 Alimera Sciences Recent Development
12.3 Allergan
12.3.1 Allergan Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ocular Drug Delivery Technology Introduction
12.3.4 Allergan Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.3.5 Allergan Recent Development
12.4 Valeant Pharmaceuticals International
12.4.1 Valeant Pharmaceuticals International Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ocular Drug Delivery Technology Introduction
12.4.4 Valeant Pharmaceuticals International Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.4.5 Valeant Pharmaceuticals International Recent Development
12.5 EyeGate Pharma
12.5.1 EyeGate Pharma Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ocular Drug Delivery Technology Introduction
12.5.4 EyeGate Pharma Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.5.5 EyeGate Pharma Recent Development
12.6 Envisia Therapeutics
12.6.1 Envisia Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ocular Drug Delivery Technology Introduction
12.6.4 Envisia Therapeutics Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.6.5 Envisia Therapeutics Recent Development
12.7 Clearside Biomedical
12.7.1 Clearside Biomedical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ocular Drug Delivery Technology Introduction
12.7.4 Clearside Biomedical Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.7.5 Clearside Biomedical Recent Development
12.8 Graybug Vision
12.8.1 Graybug Vision Company Details
12.8.2 Company Description and Business Overview
12.8.3 Ocular Drug Delivery Technology Introduction
12.8.4 Graybug Vision Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.8.5 Graybug Vision Recent Development
12.9 Santen Pharmaceutical
12.9.1 Santen Pharmaceutical Company Details
12.9.2 Company Description and Business Overview
12.9.3 Ocular Drug Delivery Technology Introduction
12.9.4 Santen Pharmaceutical Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.9.5 Santen Pharmaceutical Recent Development
12.10 Taiwan Liposome Company
12.10.1 Taiwan Liposome Company Company Details
12.10.2 Company Description and Business Overview
12.10.3 Ocular Drug Delivery Technology Introduction
12.10.4 Taiwan Liposome Company Revenue in Ocular Drug Delivery Technology Business (2017-2020)
12.10.5 Taiwan Liposome Company Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
